Literature DB >> 6112090

Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.

T L Svendsen, O J Hartling, J Trap-Jensen, A McNair, J Bliddal.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6112090     DOI： 10.1038/clpt.1981.100

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  23 in total

1.  Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.

Authors:  M Rehling; T L Svendsen; N Maltbaek; M Tangø; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Authors:  G T Tucker; N D Bax; M S Lennard; S Al-Asady; H S Bharaj; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

3.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

4.  Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.

Authors:  P Fitscha; W Meisner; B Tiso
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity have any influence during chronic therapy?

Authors:  R J Northcote; M B Cooke; D Ballantyne
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

6.  Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.

Authors:  J Bonde; T L Svendsen; K Lyngborg; J Mehlsen; J Trap-Jensen
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

7.  Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.

Authors:  P C O'Connor; J M Arnold; A N Brown; R J Francis; M B Finch; D B Galloway; D W Harron; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

Review 8.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

9.  Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.

Authors:  J Trap-Jensen; J E Carlsen; O J Hartling; T L Svendsen; M Tangø; N J Christensen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 10.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.